Canine Pancreatic Cancer: Carcinoma and Insulinoma

At Animal Cancer Care Clinic (ACCC), we understand that receiving a diagnosis of pancreatic cancer in your beloved dog can be a deeply concerning and emotional experience. Please know that our dedicated and compassionate team is here to support you and your furry companion every step of the way. Pancreatic cancers are complex, with different types having vastly different behaviors and prognoses. We have advanced diagnostic and treatment options available at ACCC aimed at alleviating symptoms, managing the disease, and maximizing your dog’s quality of life.

What is the Pancreas and Canine Pancreatic Cancer?

The pancreas is a vital gland located in the abdomen, near the stomach and small intestine (duodenum). It has two main functions:

  • Exocrine Function: Produces digestive enzymes that are secreted into the small intestine to help break down food.
  • Endocrine Function: Produces hormones, primarily insulin and glucagon, which regulate blood sugar levels.

Pancreatic cancer refers to malignant tumors that originate from cells within the pancreas. In dogs, the two most common types of primary pancreatic cancer are:

  1. Exocrine Pancreatic Carcinoma (often Adenocarcinoma):
    • This type arises from the exocrine tissue responsible for producing digestive enzymes.
    • Behavior: Exocrine pancreatic carcinoma (most commonly adenocarcinoma) is a highly aggressive and rapidly progressive cancer in dogs. It is usually diagnosed at an advanced stage, as it tends to invade surrounding tissues locally (e.g. bile duct, intestines) and has a very high tendency to spread(metastasize) early to regional lymph nodes, liver, lungs, and other abdominal organs.
  2. Insulinoma (Pancreatic Islet Cell Tumor):
    • This type arises from the endocrine tissue (specifically, the insulin-producing beta cells in the pancreatic islets).
    • Behavior: Insulinomas cause symptoms by overproducing insulin, leading to dangerously low blood sugar levels (hypoglycemia). While insulinomas are almost always malignant and have a high potential for metastasis (most commonly to regional lymph nodes and the liver), they often grow more slowly than exocrine carcinomas. The primary challenge is managing the life-threatening hypoglycemia.

It is critical to distinguish between these two types, as their clinical signs, prognosis, and treatment approaches are vastly different. Cancer from other parts of the body can also rarely spread to the pancreas (metastatic disease).

What Causes Canine Pancreatic Cancer?

The exact cause of most pancreatic cancers in dogs is not fully understood. However, some factors are believed to play a role:

  • Age: Both exocrine pancreatic carcinoma and insulinoma are generally more common in middle-aged to older dogs.
  • Breed Predisposition:
    • Exocrine Pancreatic Carcinoma: Some studies suggest breeds like Labrador Retrievers, Airedale Terriers, Boxers, and Spaniel breeds may have a higher risk. Females may be more commonly affected.
    • Insulinoma: Breeds such as Boxers, German Shepherds, Irish Setters, Fox Terriers, and Standard Poodles may have an increased risk.
  • Chronic Pancreatitis: While rare, some theories suggest that long-term, severe chronic inflammation of the pancreas (pancreatitis) might increase the risk of exocrine pancreatic carcinoma, but this link is not definitively established.

Canine pancreatic cancer is not contagious to other pets or humans.

Signs and Symptoms of Canine Pancreatic Cancer:

The signs and symptoms of pancreatic cancer in dogs can vary significantly depending on the type of tumor.

1. Signs of Exocrine Pancreatic Carcinoma (Adenocarcinoma): These signs are often vague, non-specific, and rapidly progressive, mimicking severe pancreatitis or other abdominal diseases:

  • Vomiting and/or Diarrhea: Persistent or intermittent.
  • Loss of Appetite (Anorexia) and Weight Loss: Often severe and progressive.
  • Lethargy and Weakness: Your dog may seem very tired and unwell.
  • Abdominal Pain: Signs of discomfort or tenderness when the abdomen is touched.
  • Abdominal Distension: Due to a large tumor, fluid accumulation, or severe pancreatitis.
  • Jaundice (Yellowish Skin/Gums/Eyes): If the tumor obstructs the bile duct.
  • Difficulty Breathing: If the cancer has spread to the lungs.
  • Chronic Pancreatitis or Exocrine Pancreatic Insufficiency (EPI): Rarely, the tumor can damage enough pancreatic tissue to cause these conditions, leading to digestive issues.

2. Signs of Insulinoma: These signs are primarily related to low blood sugar (hypoglycemia) and are often episodic, meaning they may come and go:

  • Weakness, Lethargy, and Exercise Intolerance: Especially after periods without food or after exercise.
  • Disorientation or Confusion: Your dog may seem “drunk” or disoriented.
  • Wobbly Gait (Ataxia) or Incoordination.
  • Trembling or Muscle Twitching.
  • Collapse or Fainting.
  • Seizures: In severe cases of hypoglycemia, brain cells are deprived of glucose.
  • Unusual Behavior: Such as staring blankly or anxiety.
  • Increased Appetite: Paradoxically, some dogs may have a ravenous appetite to try and compensate for low blood sugar.

If your dog exhibits any of these persistent or worsening signs, it’s important to seek veterinary attention promptly.

How is Canine Pancreatic Cancer Diagnosed?

Diagnosing pancreatic cancer in dogs typically involves a comprehensive and challenging approach:

  • Physical Examination: Our veterinarians will perform a thorough physical examination, including careful abdominal palpation.
  • Blood Work:
    • Complete Blood Count (CBC): To check for anemia, infection, and other abnormalities.
    • Serum Chemistry Profile: To assess organ function (liver, kidney), electrolytes, and blood glucose levels.
      • For Insulinoma: Simultaneous low blood glucose (hypoglycemia) and high blood insulin levels are key diagnostic indicators. Special blood tests (glucose:insulin ratio) may be performed.
      • For Exocrine Carcinoma: Blood tests may show elevated liver enzymes, signs of inflammation, or anemia.
  • Abdominal Imaging (Ultrasound and/or CT Scan): These are essential for attempting to visualize pancreatic masses and assess their extent and relationship to surrounding organs.
    • Abdominal Ultrasound: Can identify pancreatic masses, evaluate regional lymph nodes, and check for metastasis to the liver or other abdominal organs. Pancreatic masses can sometimes be small and difficult to detect.
    • CT Scan (Computed Tomography): Often considered the preferred imaging modality, especially for insulinomas, due to its higher sensitivity for detecting small pancreatic masses and assessing local invasion and metastasis compared to ultrasound.
  • Biopsy (Surgical is often definitive): A definitive diagnosis of the specific type of pancreatic cancer requires a tissue sample.
    • Fine Needle Aspirate (FNA): May be attempted with ultrasound guidance, but due to the small size of some pancreatic tumors and the risk of complications (e.g. pancreatitis), it may not always be performed or definitive.
    • Surgical Biopsy (Exploratory Laparotomy): This procedure often provides the most definitive diagnosis and allows for assessment of resectability and metastasis. It involves surgically opening the abdomen to directly visualize and biopsy the pancreas, regional lymph nodes, and other organs.
  • Histopathology: The collected biopsy samples are sent to a specialized pathologist for microscopic examination to confirm the specific type of cancer (exocrine carcinoma vs. insulinoma) and assess its grade.
  • Staging: For both types of pancreatic cancer, thorough staging tests are crucial to check for metastasis:
    • Thoracic Radiographs (X-rays) or CT Scan of the Chest: To check for spread to the lungs.

Treatment Options for Canine Pancreatic Cancer:

Treatment for canine pancreatic cancer is highly dependent on the specific type of tumor, its location, stage (whether it has spread), and your dog’s overall health.

1. Treatment for Exocrine Pancreatic Carcinoma (Adenocarcinoma): This is a very challenging cancer to treat.

  • Surgery: Surgical removal of the tumor (partial pancreatectomy) is theoretically the best option for local control. However, complete surgical removal is rarely possible due to the invasive nature of these tumors and the high likelihood of metastasis by the time of diagnosis. Surgery is generally only considered in very early, localized cases without obvious spread.
  • Chemotherapy: Traditional cytotoxic chemotherapy has generally shown little success in treating exocrine pancreatic carcinoma in dogs. Its use is usually limited due to poor efficacy.
  • Palladia Therapy: Palladia is a growth receptor inhibitor drug that is used for the treatment of a number of cancers in dogs. It has shown anecdotal benefit for dogs with pancreatic adenocarcinoma.
  • Palliative Care: For most dogs with exocrine pancreatic carcinoma, treatment focuses on supportive and palliative care to manage symptoms and maintain quality of life for as long as possible. This includes pain management, anti-nausea medications, and appetite stimulants.

2. Treatment for Insulinoma: The primary goals are to remove the tumor and/or manage the hypoglycemia.

  • Surgery (Partial Pancreatectomy): Surgical removal of the pancreatic tumor is the treatment of choice for insulinoma. This offers the best chance for relief from hypoglycemia and can improve survival time. However, insulinomas are often small and difficult to locate during surgery, and multiple tumors or metastatic lesions may be present, making complete removal challenging. Surgery often provides temporary control rather than a complete cure, as microscopic disease is usually present.
  • Medical Management of Hypoglycemia: This is crucial for all dogs with insulinoma, especially for long-term control after surgery, or as the primary management if surgery is not feasible or chosen.
    • Dietary Management: Frequent small meals (4-6 times daily) of a diet rich in protein, fat, and complex carbohydrates (to provide sustained glucose release) and low in simple sugars.
    • Corticosteroids (e.g. Prednisone): Can help raise blood sugar levels.
    • Diazoxide: An oral medication that helps to inhibit insulin release and raise blood glucose.
    • Octreotide: Another medication that can inhibit insulin release in some cases.
  • Chemotherapy: The role of chemotherapy for insulinoma is to control metastatic disease. The drug streptozotocin has been used, but it carries significant risks of severe side effects (including kidney toxicity). Other chemotherapeutic agents or targeted therapies (e.g. Palladia) may be considered.
  • Palladia Therapy: Palladia is a growth receptor inhibitor drug that is used for the treatment of a number of cancers in dogs. It has shown benefit for dogs with insulinoma.

What to Expect During and After Treatment:

If your dog undergoes treatment for pancreatic cancer at Animal Cancer Care Clinic, you can expect:

  • Intensive Post-Surgical Care (if applicable): This includes careful monitoring for complications (e.g. pancreatitis, diabetes mellitus, continued hypoglycemia), pain management, and nutritional support.
  • Close Monitoring: Our team will closely monitor your dog’s clinical signs, blood glucose levels (for insulinoma), and overall health.
  • Management of Potential Side Effects: We will proactively manage any potential side effects from surgery or systemic therapies.
  • Regular Follow-Up Appointments: These appointments will involve physical examinations, blood work (especially glucose for insulinoma), and repeat imaging studies (chest radiographs, abdominal ultrasound) to monitor for recurrence or metastasis.

Prognosis for Canine Pancreatic Cancer:

The prognosis for dogs with pancreatic cancer varies depending on the specific type of tumor and whether it has spread:

  • Exocrine Pancreatic Carcinoma (Adenocarcinoma): The prognosis is generally very guarded. Due to the aggressive nature, rapid progression, and high metastatic rate, most dogs are diagnosed at an advanced stage where surgery is not curative, and chemotherapy has limited efficacy. Survival times are typically very short, with a very low possibility of long-term control.
  • Insulinoma: The prognosis is guarded but often offers a longer quality of life compared to exocrine carcinoma. While almost always malignant and prone to metastasis, effective management of hypoglycemia can significantly improve quality of life and extend survival.
    • With successful surgery (even if not curative) and diligent medical management, median survival times are measured in years, especially for those achieving normal blood glucose post-op.
    • If surgery is not possible, or if there is significant metastasis, medical management alone can still provide a good quality of life for months to years.

We will discuss the potential prognosis for your dog based on their individual diagnosis and the chosen treatment plan at ACCC. Our goal is to provide realistic expectations while focusing on maximizing their comfort and quality of life for as long as possible.

Coping with a Pancreatic Cancer Diagnosis:

Receiving a diagnosis of pancreatic cancer for your dog can be incredibly difficult, especially given the seriousness of both tumor types. Please know that the team at Animal Cancer Care Clinic is here to offer not only the best possible medical care for your dog but also compassionate support for you and your family during this difficult time.

We encourage you to ask us any questions you have and to share your feelings and concerns openly. We want you to feel informed and supported as you make important decisions about your dog’s care.

Our commitment is to work with you to develop a treatment plan that is tailored to your dog’s needs and your wishes, while always prioritizing their comfort, health, and your shared bond.

Questions to Ask Your Veterinarian:

To help you better understand your dog’s condition and the treatment options available, here are some questions you may find helpful to ask us:

  • What specific type of pancreatic cancer does my dog have (exocrine pancreatic carcinoma/adenocarcinoma, or insulinoma)?
  • Has the cancer spread to regional lymph nodes or other parts of the body (e.g. liver, lungs)?
  • What are my dog’s current blood glucose levels and insulin levels (if applicable)?
  • What are the recommended treatment options for my dog’s pancreatic cancer?
  • What are the potential risks and complications of surgery (if recommended), especially the risk of pancreatitis?
  • Is chemotherapy or targeted therapy recommended? What are its goals and potential side effects?
  • What is the expected prognosis for my dog with the recommended treatment?
  • How will my dog’s symptoms (e.g. vomiting, abdominal pain, hypoglycemia/seizures) be managed?
  • Will my dog need dietary changes or frequent feedings?
  • What is the estimated cost of the recommended treatment plan and ongoing care?
  • What can I do at home to best support my dog during this time?

Conclusion:

At Animal Cancer Care Clinic, we are dedicated to providing compassionate and comprehensive care for dogs with pancreatic cancer. Our experienced team will work closely with you to develop a personalized treatment plan focused on managing the disease and maximizing your dog’s quality of life. Please do not hesitate to reach out to us with any questions or concerns you may have. We are here to support you and your cherished canine companion through this challenging journey.